| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |